Potential fate of ingested Lactobacillus plantarum and its occurrence in human feces

Applied and Environmental Microbiology

Volumn 80, Issue 3, 2014, Pages 1013-1019

  Costa, Giselle Nobre ^a,b   Marcelino Guimarães, Francismar Corrêa ^c   Vilas Bôas, Gislayne Trindade ^a   Matsuo, Tiemi ^a   Miglioranza, Lucia Helena S ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

^c EMBRAPA CERRADOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BASELINE LEVELS; BENEFICIAL EFFECTS; CARDIO-VASCULAR DISEASE; FECAL MICROBIOTA; FERMENTATION PROCESS; GASTROINTESTINAL TRACT; LACTOBACILLUS PLANTARUM; QUANTITATIVE PCR;

FERMENTATION; POLYMERASE CHAIN REACTION;

BACILLI;

BACTERIUM; CARDIOVASCULAR DISEASE; FECES; MICROBIAL ACTIVITY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RISK FACTOR;

ARTICLE; BACTERIAL LOAD; DIET; FECES; HUMAN; ISOLATION AND PURIFICATION; LACTOBACILLUS PLANTARUM; METHODOLOGY; MICROBIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

BACTERIAL LOAD; DIET; FECES; HUMANS; LACTOBACILLUS PLANTARUM; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84892998758     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02588-13     Document Type: Article

References (47)

1. Gill HS, Darragh AJ, Cross ML. 2001. Optimizing immunity and gut function in the elderly. J. Nutr. Health Aging 5:80-91.
2. Isolauri E, Salminen S, Ouwehand AC. 2004. Probiotics. Best Pract. Res. Clin. Gastroenterol. 18:299-313. http://dx.doi.org/10.1016/j.bpg.2003.10 .006.
3. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-848. http://dx.doi.org/10.1016/j.cell.2006.02.017.
4. Tiihonen K, Ouwehand AC, Rautonen N. 2010. Human intestinal microbiota and healthy ageing. Ageing Res. Rev. 9:107-116. http://dx.doi.org /10.1016/j.arr.2009.10.004.
5. Jankovic I, Sybesma W, Phothirath P, Ananta E, Mercenier A. 2010. Application of probiotics in food products-challenges and new approaches. Curr. Opin. Biotechnol. 21:175-181. http://dx.doi.org/10.1016 /j.copbio.2010.03.009.
6. Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T. 2000. Probiotic bacteria: safety, functional and technological properties. J. Biotechnol. 84:197-215. http://dx.doi.org/10.1016/S0168-1656(00)00375-8.
7. Carey CM, Kirk JL, Ojha S, Kostrzynska M. 2007. Current and future uses of real time polymerase chain reaction and microarrays in the study of intestinal microbiota and probiotic use and effectiveness. Can. J. Microbiol. 53:537-550. http://dx.doi.org/10.1139/W07-039.
8. Gueimonde M, Tolkko S, Korpimki T, Salminen S. 2004. New real-time quantitative PCR procedure for quantification of Bifidobacteria in human fecal samples. Appl. Environ. Microbiol. 70:4165-4169. http://dx.doi.org /10.1128/AEM.70.7.4165-4169.2004.
9. Zoetendal EG, Rajilić-Stojanović M, de Vos WM. 2008. Highthroughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57:1605-1615. http://dx.doi.org/10.1136/gut.2007 .133603.
10. Postollec F, Falentin H, Pavan S, Combrisson J, Sohi D. 2011. Recent advances in quantitative PCR (qPCR) applications in food microbiology. Food Microbiol. 28:848-861. http://dx.doi.org/10.1016/j.fm.2011.02.008.
11. Palmer S, Wiegand A, Maldarelli F, Bazmi H, Mican J, Polis M, Dewar R, Planta A, Liu S, Metcalf J, Mellors J, Coffin J. 2003. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 41:4531-4536. http://dx.doi.org/10.1128/JCM.41.10.4531-4536.2003.
12. Kramer M, Obermajer N, Matijašić BB, Rogelj I, Kmetec V. 2009. Quantification of live and dead probiotic bacteria in lyophilised product by real-time PCR and by flow cytometry. Appl. Microbiol. Biotechnol. 84:1137-1147. http://dx.doi.org/10.1007/s00253-009-2068-7.
13. Masco L, Vanhoutte L, Temmerman R, Swings J, Huys G. 2007. Evaluation of real-time PCR targeting the 16S rRNA and recA genes for the enumeration of bifidobacteria in probiotic products. Int. J. Food Microbiol. 113:351-357. http://dx.doi.org/10.1016/j.ijfoodmicro.2006.07.021.
14. Fujimoto J, Matsuki T, Sasamoto M, Tomii Y, Watanabe K. 2008. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. Int. J. Food Microbiol. 126:210-215. http://dx .doi.org/10.1016/j.ijfoodmicro.2008.05.022.
15. Gopal PK, Prasad J, Gill HS. 2003. Effects of the consumption of Bifidobacterium lactis HN019 (DR10) and galacto-oligosaccharides on the microflora of the gastrointestinal tract in the human subjects. Nutr. Res. 23:1313-1328. http://dx.doi.org/10.1016/S0271-5317(03)00134-9.
16. Hugenschmidt S, Schwenninger SM, Gnehm N, Lacroix C. 2010. Screening of a natural biodiversity of lactic and propionic acid bacteria for folate and vitamin B12 production in supplemented whey permeate. Int. Dairy J. 20:852-857. http://dx.doi.org/10.1016/j.idairyj.2010.05.005.
17. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. 2002. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 76:1249-1255.
18. Paolillo R, Carratelli CR, Sorrentino S, Mazzola N, Rizzo A. 2009. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int. Immunopharmacol. 9:1265-1271. http://dx.doi.org/10 .1016/j.intimp.2009.07.008.
19. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, Mckenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116:1310-1316. http://dx.doi.org/10.1172/JCI21404.
20. Kleerebezem M, Boekhorst J, Van Kranenburg R, Molenaar D, Kuipers OP, Leer R, Tarchini R, Peters SA, Sandbrink HM, Fiers MW, Stiekema W, Lankhorst RM, Bron PA, Hoffer SM, Groot MN, Kerkhoven R, de Vries M, Ursing B, de Vos WM, Siezen RJ. 2003. Complete genome sequence of Lactobacillus plantarum WCFS1. Proc. Natl. Acad. Sci. U. S. A. 100:1990-1995. http://dx.doi.org/10.1073/pnas.0337704100.
21. Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. 2008. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol. Med. Microbiol. 53:107-113. http://dx.doi.org/10.1111/j.1574-695X .2008.00413.x.
22. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B. 2006. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl. Environ. Microbiol. 72:5799-5805. http://dx .doi.org/10.1128/AEM.00109-06.
23. Costa GN, Villas-Bôas GT, Villas-Boas LA, Miglioranza LHS. 2011. In silico phylogenetic analysis of lactic acid bacteria and new primer set for identification of Lactobacillus plantarum in food samples. Eur. Food Res. Technol. 233:233-241. http://dx.doi.org/10.1007/s00217-011-1508-7.
24. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. http://dx.doi.org/10.1093 /nar/29.9.e45.
25. Larsen N, Vogensen FK, Gøbel R, Michaelsen KF, Abu Al-Soud W, Sørensen SJ, Hansen LH, Jakobsen M. 2011. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. FEMS Microbiol. Ecol. 75:482-496. http://dx .doi.org/10.1111/j.1574-6941.2010.01024.x.
26. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J. 2006. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24:6670-6674. http://dx.doi.org/10.1016/j.vaccine.2006.05.048.
27. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. 2009. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124:e172-e179. http://dx.doi.org/10.1542/peds.2008 -2666.
28. Böhm-Hofstätter H, Tschernutter M, Kunert R. 2010. Comparison of hybridization methods and real-time PCR: their value in animal cell line characterization. Appl. Microbiol. Biotechnol. 87:419-425. http://dx.doi .org/10.1007/s00253-010-2580-9.
29. Matijašić BB, Obermajer T, Rogelj I. 2010. Quantification of Lactobacillus gasseri, Enterococcus faecium and Bifidobacterium infantis in a probiotic OTC drug by real-time PCR. Food Control 21:419-425. http://dx.doi.org /10.1016/j.foodcont.2009.07.001.
30. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonák J, Lind K, Sindelka R, Sjöback R, Sjögreen B, Strömbom L, Ståhlberg A, Zoric N. 2006. The real-time polymerase chain reaction. Mol. Aspects Med. 27:95-125. http://dx.doi.org/10.1016/j.mam.2005.12.007.
31. Dang W, Sun L. 2011. Determination of internal controls for quantitative real time RT-PCR analysis of the effect of Edwardsiella tarda infection on gene expression in turbot (Scophthalmus maximus). Fish Shellfish Immunol. 30:720-728. http://dx.doi.org/10.1016/j.fsi.2010.12.028.
32. Ginzinger DG. 2002. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp. Hematol. 30:503-512. http://dx.doi.org/10.1016/S0301-472X(02)00806-8.
33. CT method. Methods 25: 402-408. http://dx.doi.org/10.1006/meth.2001.1262.
34. Lu S, Smith AP, Moore D, Lee NM. 2010. Different real-time PCR systems yield different gene expression values. Mol. Cell. Probes 24:315-320. http://dx.doi.org/10.1016/j.mcp.2010.04.002.
35. Liu W, Saint DA. 2002. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal. Biochem. 302:52-59. http://dx .doi.org/10.1006/abio.2001.5530.
36. Adlerberth I, Ahrné S, Johansson ML, Molin G, Hanson LA, Wold AE. 1996. A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl. Environ. Microbiol. 62:2244-2251.
37. Dhanani AS, Gaudana SB, Bagchi T. 2011. The ability of Lactobacillus adhesin EF-Tu to interfere with pathogen adhesion. Eur. Food Res. Technol. 232:777-785. http://dx.doi.org/10.1007/s00217-011-1443-7.
38. Molin G, Jeppson B, Johansson ML, Ahrné S, Nobaek S, Ståhl M, Bengmark S. 1993. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J. Appl. Microbiol. 74:314-323. http://dx.doi.org/10.1111/j.1365-2672.1993.tb03031.x.
39. Wang CY, Lin PR, Ng CC, Shyu YT. 2010. Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage. Anaerobe 16:578-585. http://dx.doi.org/10.1016 /j.anaerobe.2010.10.003.
40. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, Von Wright A. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65:351-354.
41. de Champs C, Maroncle N, Balestrino D, Rich C, Forestier C. 2003. Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35 after oral consumption. J. Clin. Microbiol. 41:1270-1273. http://dx.doi.org/10.1128/JCM.41.3.1270 -1273.2003.
42. Saito Y, Sakamoto M, Takizawa S, Benno S. 2004. Monitoring the cell number and viability of Lactobacillus helveticus GCL1001 in human feces by PCR methods. FEMS Microbiol. Lett. 231:125-130. http://dx.doi.org /10.1016/S0378-1097(03)00951-0.
43. Tannock GW, Munro K, Harmsen HJM, Welling GW, Smart J, Gopal PK. 2000. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 66:2578-2588. http://dx.doi.org/10.1128/AEM.66.6.2578 -2588.2000.
44. Heyman M, Ménard S. 2002. Probiotic microorganisms: how they affect the intestinal pathophysiology. Cell. Mol. Life Sci. 59:1151-1165. http://dx .doi.org/10.1007/s00018-002-8494-7.
45. Langhendries JP, Detry J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ, Secretin MC, Senterre J. 1995. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J. Pediatr. Gastroenterol. Nutr. 21: 177-181. http://dx.doi.org/10.1097/00005176-199508000-00009.
46. Haarman M, Knol J. 2006. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 72:2359-2365. http://dx.doi .org/10.1128/AEM.72.4.2359-2365.2006.
47. Santosa S, Farnworth E, Jones PJH. 2006. Probiotics and their potential health claims. Nutr. Rev. 64:265-274. http://dx.doi.org/10.1111/j.1753 -4887.2006.tb00209.x.